dc.contributor.author |
Marques, Daiane |
|
dc.contributor.author |
Sandrini, Juliana Zomer |
|
dc.contributor.author |
Boyle, Robert Tew |
|
dc.contributor.author |
Marins, Luis Fernando Fernandes |
|
dc.contributor.author |
Trindade, Gilma Santos |
|
dc.date.accessioned |
2011-11-17T06:40:43Z |
|
dc.date.available |
2011-11-17T06:40:43Z |
|
dc.date.issued |
2009 |
|
dc.identifier.citation |
MARQUES, D. S. et al. Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines. Leukemia Research , v. 34, p. 757-762, 2010. Disponível em: <http://www.inct-ta.furg.br/english/producao/262010.pdf>. Acesso em: 03 nov. 2011. |
pt_BR |
dc.identifier.issn |
0145-2126 |
|
dc.identifier.uri |
http://repositorio.furg.br/handle/1/1353 |
|
dc.description.abstract |
The K562 cell line (chronic myeloid leukemia), sensitive to chemotherapy (non-MDR), and the Lucena cell
line, resistant to chemotherapy (MDR) were investigated. The results suggest that both cell lines possess CD34 + CD38 − profiles of hematopoietic stem cell markers. The promoter regions of ABCB1, ABCG2 and
ABCC1 genes contain binding sites for the Oct-4 transcripton factor,which is also considered a marker of tumor stem cells. Lucena cells showed an over-expression of the ABCB1 gene and a high expression of
the Oct-4, ABCG2 and ABCC1 genes as compared to K562 cells. |
pt_BR |
dc.language.iso |
eng |
pt_BR |
dc.rights |
restrict access |
pt_BR |
dc.subject |
CML |
pt_BR |
dc.subject |
CD34 |
pt_BR |
dc.subject |
CD38 |
pt_BR |
dc.subject |
Oct-4 |
pt_BR |
dc.subject |
ABCB1 |
pt_BR |
dc.subject |
ABCG2 |
pt_BR |
dc.subject |
ABCC1 |
pt_BR |
dc.title |
Relationship between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines |
pt_BR |
dc.type |
article |
pt_BR |